Table 2.
Variable | Pre-pandemic (Jan 1, 2019–Feb 24, 2020) |
Pandemic (Feb 25, 2020–Jun 23, 2020) |
Comparison of periods* |
||||
---|---|---|---|---|---|---|---|
Treated in a stroke unit |
Treated in a stroke unit |
||||||
No | Yes | P | No | Yes | P | P | |
Provided antithrombotic medication within 48 hours of arrival† | 2,092/3,371 (62) | 8,289/11,697 (71) | <0.001 | 543/843 (64) | 1,840/2,484 (74) | <0.001 | 0.002 |
Mobilised during the admission | 3,113/4,951 (63) | 11,679/14,692 (79) | <0.001 | 719/1,578 (46) | 2,412/3,402 (71) | <0.001 | <0.001 |
Provided swallow screen or assessment | 2,478/4,631 (54) | 12,697/14,129 (90) | <0.001 | 583/1,385 (42) | 2,709/3,029 (89) | <0.001 | <0.001 |
Discharged to inpatient rehabilitation | 506/5,012 (10) | 4,234/16,249 (26) | <0.001 | 155/1,330 (12) | 987/3,578 (28) | <0.001 | 0.141 |
Prescribed antihypertensive medication at discharge | 2,656/4,059 (65) | 11,159/14,607 (76) | <0.001 | 613/1,245 (49) | 2,352/3,260 (72) | <0.001 | <0.001 |
Prescribed antithrombotic medication at discharge† | 3,157/3,773 (84) | 12,642/13,636 (93) | <0.001 | 724/1,175 (62) | 2,626/3,022 (87) | <0.001 | <0.001 |
Prescribed lipid lowering medication at discharge† | 2,587/3,769 (69) | 11,039/13,649 (81) | <0.001 | 616/1,177 (52) | 2,268/3,004 (76) | <0.001 | <0.001 |
Discharged to the community with a care plan | 1,303/2,656 (49) | 5,576/7,499 (74) | <0.001 | 322/624 (52) | 1,284/1,606 (80) | <0.001 | <0.001 |
Values are presented as number/total number (%).
Patients within periods were aggregated in this comparison;
Excluding patients with intracerebral hemorrhage.